Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Dec 22, 2010

Premium

Personalized medicine company TcLand Expression announced the appointment of Peter Payne as its chief business officer, as well as the head of its US Operations.

Before joining TcLand Expressions, Payne worked for Quintiles Transnational Corp where he held various positions managing senior operations and business development in Europe and the US. Most recently, he was VP of corporate development at Quintiles responsible for inking strategic relationships with drug firms, venture capital funds, and other financial institutions.

TcLand Expression is developing personalized medicine companion diagnostics in immune mediated disorders and is clinically validating personalized medicine biomarkers for tolerance in liver transplantation.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more